Polypharmacy as the risk factor of potentially inappropriate medication and medication regimen complexity index in hospitalised elderly patients
DOI:
https://doi.org/10.46542/pe.2023.234.325330Keywords:
Beers criteria 2019, Medication regimen complexity, Medication regimen complexity index, Polypharmacy, Potentially inappropriate medicationAbstract
Background: The majority of elderly patients often receive complex therapy or polypharmacy due to physiological changes, which can develop into an adverse drug event.
Objective: To analyse the risk factors of potentially Inappropriate Medications (PIMs) and medication regimen complexity in elderly patients.
Method: This is an observational study with cohort retrospective methods, carried out at the In-patient Unit of Airlangga University Hospital, Surabaya. The inclusion criteria were patients aged ≥ 60 years old who were admitted between January to December 2019 for at least three days and received at least one drug. PIMs were monitored with Beers Criteria 2019 and therapy complexity was measured with Medication Regimen Complexity Index (MRCI) during admission, hospitalisation, and discharge.
Result: Among 357 patients, 60.8% received at least one PIM on admission. Furthermore, the MRCI score decreased from 22.7 at the time of admission to 11.5 on discharge. Patients who received polypharmacy were two to three times more at risk of having PIMs (p < 0.001). The number of medications correlated with the MRCI scores (Correlation Coefficient= 0.815–0.877, p < 0.001).
Conclusion: Polypharmacy is one of the risk factors of PIMs and medication regimen complexity, elderly patients who receive polypharmacy must be closely monitored to prevent adverse drug reactions.
References
Abdulah, R., Insani, W.N., Destiani, D.P., Rohmaniasari, N., Mohenathas, N.D., & Barliana, M.I. (2018). Polypharmacy leads to an increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Therapeutics and clinical risk management, 14, 1591–1597. https://doi.org/10.2147/TCRM.S170475
Al-Azayzih, A., Alamoori, R., & Altawalbeh, S.M. (2019). Potentially inappropriate medications prescribing according to Beer’s criteria among elderly outpatients in Jordan: A cross-sectional study. Pharmacy Practice, 17(2), 1439.
Alhawassi, T.M., Alatawi, W., & Alwhaibi, M. (2019). Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC geriatrics, 19(1), 154. https://doi.org/10.1186/s12877-019-1168-1
American Geriatrics Society Beers Criteria® Update Expert Panel. (2019). American geriatrics society 2019 updated AGS beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. https://doi.org/10.1111/jgs.15767
Chang, W.T., Kowalski, S.R., Sorich, W., & Alderman, C.P. (2017). Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation. International journal of clinical pharmacy, 39(4), 867–873. https://doi.org/10.1007/s11096-017-0490-y
Charlson M.E., Carrozzino D., Guidi J., & Patierno C. (2022). Charlson comorbidity index: A critical review of clinometric properties. Psychother Psychosom, 91, 8-35. https://doi.org/10.1159/000521288
Chivapricha, W., Srinonprasert, V., & Suansanae, T. (2021). Impact of geriatric pharmacy specialist interventions to reduce potentially inappropriate medication among hospitalized elderly patients at medical wards: A prospective quasi-experimental study. Drugs - real-world outcomes, 8(1), 39–47. https://doi.org/10.1007/s40801-020-00214-7
Dagli, R.J., & Sharma, A. (2014). Polypharmacy: A global risk factor for elderly people. Journal of International Oral Health: JIOH, 6(6), i–ii.
Faustino, C.G., Martins, M., & Jacob Filho, W. (2011). Potentially inappropriate medication prescribed to elderly outpatients at a general medicine unit. Einstein (Sao Paulo, Brazil), 9(1), 18–23. https://doi.org/10.1590/S1679-45082011AO1844
George, J., Phun, Y.T., Bailey, M.J., Kong, D.C., & Stewart, K. (2004). Development and validation of the medication regimen complexity index. The Annals of Pharmacotherapy, 38(9), 1369–1376. https://doi.org/10.1345/aph.1D479
Giardina, C., Cutroneo, P.M., Mocciaro, E., Russo, G.T., Mandraffino, G., Basile, G., Rapisarda, F., Ferrara, R., Spina, E., & Arcoraci, V. (2018). Adverse drug reactions in hospitalised patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Frontiers in pharmacology, 9, 350. https://doi.org/10.3389/fphar.2018.00350
Jo, Y.Y., Kim, Y.B., Yang, M.R., & Chang, Y.J. (2012). Extrapyramidal side effects after metoclopramide administration in a post-anaesthesia care unit -A case report. Korean Journal of anaesthesiology, 63(3), 274–276. https://doi.org/10.4097/kjae.2012.63.3.274
Lee, S., Jang, J., Yang, S., Hahn, J., Min, K.L., Jung, E.H., Oh, K.S., Cho, R., & Chang, M.J. (2019). Development and validation of the Korean version of the medication regimen complexity index. PloS one, 14(5), e0216805. https://doi.org/10.1371/journal.pone.0216805
Linnebur, S.A., Vande Griend, J.P., Metz, K.R., Hosokawa, P. W., Hirsch, J.D., & Libby, A.M. (2014). Patient-level medication regimen complexity in older adults with depression. Clinical therapeutics, 36(11), 1538–1546.e1. https://doi.org/10.1016/j.clinthera.2014.10.004
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G.E. (2017). What is polypharmacy? A systematic review of definitions. BMC geriatrics, 17(1), 230. https://doi.org/10.1186/s12877-017-0621-2
Negewo, N.A., Gibson, P.G., Wark, P.A., Simpson, J.L., & McDonald, V.M. (2017). Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. International journal of chronic obstructive pulmonary disease, 12, 2929–2942. https://doi.org/10.2147/COPD.S136256
Osei, E.K., Berry-Cabán, C.S., Haley, C.L., & Rhodes-Pope, H. (2016). Prevalence of beers criteria medications among elderly patients in a military hospital. Gerontology & geriatric medicine, 2, 2333721416637790. https://doi.org/10.1177/2333721416637790
Pantuzza, L.L., Ceccato, M., Silveira, M.R., Pinto, I.V., & Reis, A. (2018). Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care. Geriatrics & gerontology international, 18(6), 853–859. https://doi.org/10.1111/ggi.13261
Rieckert, A., Trampisch, U.S., Klaaßen-Mielke, R., Drewelow, E., Esmail, A., Johansson, T., Keller, S., Kunnamo, I., Löffler, C., Mäkinen, J., Piccoliori, G., Vögele, A., & Sönnichsen, A. (2018). Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC family practice, 19(1), 113. https://doi.org/10.1186/s12875-018-0795-5
Sharma, R., Chhabra, M., Vidyasagar, K., Rashid, M., Fialova, D., & Bhagavathula, A.S. (2020). Potentially Inappropriate Medication Use in Older Hospitalised Patients with Type 2 Diabetes: A Cross-Sectional Study. Pharmacy (Basel, Switzerland), 8(4), 219 https://doi.org/10.3390/pharmacy8040219
